Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Léčba diabetu transplantací izolovaných Langerhansových ostrůvků
[Islet transplantation for treatment of type-1 diabetes mellitus]

František Saudek, Peter Girman, Jan Kříž, Zuzana Berková, Klára Zacharovová, Tomáš Koblas, Lenka Pektorová, Ema Vávrová, Martina Mindlová, David Habart, Jan Peregrin, Květoslav Lipár, Martin Oliverius, Eva Dovolilová, Evžena Číhalová, Vít Bobek

Jazyk čeština Země Česko

Typ dokumentu kazuistiky

Perzistentní odkaz   https://www.medvik.cz/link/bmc11003780

Organ pancreas transplantation represents the only method enabling long-term normalization of glucose metabolism in type-1 diabetic subjects so far. Unfortunately, surgical complications of this kind of therapy are still frequent. As a safer alternative, transplantation of isolated pancreatic islets was introduced at the Institute for Clinical and Experimental Medicine as a clinical experiment in the year 2005. METHODS AND RESULTS: We isolated the islets from pancreases of cadaveric donors which did not fulfil criteria to perform organ pancreas transplantation. Altogether, 36 islet implantations were performed in 28 C-peptide negative subjects suffering from type-1 diabetes by August 2010. In 15 subjects (21 implantations) the main indication was extremely instable course of diabetes due to the hypoglycaemia unawareness syndrome. In 5 and 3 cases, combined islet and kidney and islet and liver transplants were performed, respectively. In addition, islet autotransplantation was performed in 5 subjects undergoing total pancreatectomy. No patient died during the study period. In all but 1 patient with primary islet afunction, islet transplantation led to a complete cure of the hypoglycemia unawareness syndrome. Out of 15 patients, 11 subjects in this group showed a significant C-peptide production (> 0.2 pmol/ml) after 1 year. The mean insulin dose after allotransplantation decreased from 37 to 14 units per day and in 3 subjects, insulin therapy could be withdrawn. Serious technical complications occurred in 6 subjects, which only in 2 cases required surgical revision and did not cause long-term sequels. CONCLUSIONS: In comparison with organ pancreas transplantation, pancreatic islet transplantation represents a substantially safer method for restitution of endogenous insulin production. Though it eliminates serious hypoglycemic episodes in labile diabetes, complete insulin withdrawal is still often not possible. However, due to continuing progress in the laboratory techniques as well as in the transplant procedure itself, the results are steadily improving.

Islet transplantation for treatment of type-1 diabetes mellitus

Bibliografie atd.

Lit.: 20

000      
00000naa 2200000 a 4500
001      
bmc11003780
003      
CZ-PrNML
005      
20250325114549.0
008      
110302s2011 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Saudek, František, $d 1955- $7 nlk20000083698
245    10
$a Léčba diabetu transplantací izolovaných Langerhansových ostrůvků / $c František Saudek, Peter Girman, Jan Kříž, Zuzana Berková, Klára Zacharovová, Tomáš Koblas, Lenka Pektorová, Ema Vávrová, Martina Mindlová, David Habart, Jan Peregrin, Květoslav Lipár, Martin Oliverius, Eva Dovolilová, Evžena Číhalová, Vít Bobek
246    11
$a Islet transplantation for treatment of type-1 diabetes mellitus
314    __
$a IKEM, Klinika diabetologie, Centrum diabetologie, Praha
504    __
$a Lit.: 20
520    9_
$a Organ pancreas transplantation represents the only method enabling long-term normalization of glucose metabolism in type-1 diabetic subjects so far. Unfortunately, surgical complications of this kind of therapy are still frequent. As a safer alternative, transplantation of isolated pancreatic islets was introduced at the Institute for Clinical and Experimental Medicine as a clinical experiment in the year 2005. METHODS AND RESULTS: We isolated the islets from pancreases of cadaveric donors which did not fulfil criteria to perform organ pancreas transplantation. Altogether, 36 islet implantations were performed in 28 C-peptide negative subjects suffering from type-1 diabetes by August 2010. In 15 subjects (21 implantations) the main indication was extremely instable course of diabetes due to the hypoglycaemia unawareness syndrome. In 5 and 3 cases, combined islet and kidney and islet and liver transplants were performed, respectively. In addition, islet autotransplantation was performed in 5 subjects undergoing total pancreatectomy. No patient died during the study period. In all but 1 patient with primary islet afunction, islet transplantation led to a complete cure of the hypoglycemia unawareness syndrome. Out of 15 patients, 11 subjects in this group showed a significant C-peptide production (> 0.2 pmol/ml) after 1 year. The mean insulin dose after allotransplantation decreased from 37 to 14 units per day and in 3 subjects, insulin therapy could be withdrawn. Serious technical complications occurred in 6 subjects, which only in 2 cases required surgical revision and did not cause long-term sequels. CONCLUSIONS: In comparison with organ pancreas transplantation, pancreatic islet transplantation represents a substantially safer method for restitution of endogenous insulin production. Though it eliminates serious hypoglycemic episodes in labile diabetes, complete insulin withdrawal is still often not possible. However, due to continuing progress in the laboratory techniques as well as in the transplant procedure itself, the results are steadily improving.
650    _2
$a dospělí $7 D000328
650    _2
$a krevní glukóza $x analýza $7 D001786
650    _2
$a diabetes mellitus 1. typu $x farmakoterapie $x chirurgie $x krev $7 D003922
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x terapeutické užití $7 D007004
650    _2
$a inzulin $x terapeutické užití $7 D007328
650    _2
$a transplantace Langerhansových ostrůvků $x metody $x přístrojové vybavení $x škodlivé účinky $7 D016381
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a komplikace diabetu $7 D048909
653    00
$a slinivka břišní
653    00
$a imunosuprese
655    _2
$a kazuistiky $7 D002363
700    1_
$a Girman, Peter $7 xx0081892
700    1_
$a Kříž, Jan, $d 1972- $7 xx0056572
700    1_
$a Berková, Zuzana $7 xx0081890
700    1_
$a Zacharovová, Klára $7 xx0074471
700    1_
$a Koblas, Tomáš $7 xx0070806
700    1_
$a Vargová, Lenka $7 xx0141859
700    1_
$a Vávrová, Ema $7 _AN049310
700    1_
$a Mindlová, Martina $7 xx0092588
700    1_
$a Habart, David $7 xx0035016
700    1_
$a Peregrin, Jan H., $d 1951- $7 mzk2006331741
700    1_
$a Lipár, Květoslav $7 xx0231456
700    1_
$a Oliverius, Martin $7 xx0106430
700    1_
$a Dovolilová, Eva $7 xx0077055
700    1_
$a Číhalová, Eugenie $7 xx0260071
700    1_
$a Bobek, Vít $7 xx0330470
773    0_
$w MED00010976 $t Časopis lékařů českých $g Roč. 150, č. 1 (2011), s. 49-55 $x 0008-7335
856    41
$u https://www.prolekare.cz/casopisy/casopis-lekaru-ceskych/2011-1-1/lecba-diabetu-transplantaci-izolovanych-langerhansovych-ostruvku-34283 $y plný text volně přístupný
910    __
$a ABA008 $b B 1 $c 1068 $y 7 $z 0
990    __
$a 20110302102004 $b ABA008
991    __
$a 20250325114549 $b ABA008
999    __
$a ok $b bmc $g 830989 $s 695803
BAS    __
$a 3
BMC    __
$a 2011 $b 150 $c 1 $d 49-55 $m Časopis lékařů českých $x MED00010976
LZP    __
$a 2011-14/vtme

Najít záznam